Wright Medical Enters Injectable BVF Market, Joining J&J/DePuy, Synthes
This article was originally published in The Gray Sheet
Executive Summary
Wright Medical Group will market its MIIG 115 minimally invasive injectable Osteoset bone graft substitute system primarily to trauma surgeons supported by a sales force of 220 commissioned reps in the U.S